The role of neoadjuvant radiotherapy for locally-advanced rectal cancer with resectable synchronous metastasis
Croix C. Fossum(University of Southern California), David W. Larson(Mayo Clinic), Christopher L. Hallemeier(Mayo Clinic in Arizona), Lindsay B. Romak(Mayo Clinic), Michael G. Haddock(Mayo Clinic in Arizona), Jasim Alabbad(Mayo Clinic), Marianne Huebner(Michigan State University), Eric J. Dozois(Mayo Clinic)
Cited by 29
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer
|Annals of Surgery|2019|445
Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)
|Journal of Clinical Oncology|2008|270
Oesophageal cancer
|The Lancet|2024|265